Texas-Yale-Capital

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-07
Total Holdings
451
Total Value
2435370018
Accession Number
0001420506-25-000913
Form Type
13F-HR
Manager Name
Texas-Yale-Capital
Data Enrichment
82% identified
371 identified80 unidentified

Holdings

451 positions • $2.4B total value
Manager:
Search and click to pin securities to the top
Page 23 of 23
CorMedix Inc.
Shares:20.0K
Value:$123.2K
% of Portfolio:0.0% ($123.2K/$2.4B)
Hanesbrands Inc.
Shares:16.2K
Value:$93.2K
% of Portfolio:0.0% ($93.2K/$2.4B)
Editas Medicine, Inc.
Shares:70.0K
Value:$81.2K
% of Portfolio:0.0% ($81.2K/$2.4B)
GABELLI EQUITY TRUST INC
Shares:10.7K
Value:$59.0K
% of Portfolio:0.0% ($59.0K/$2.4B)
GAMCO Global Gold, Natural Resources & Income Trust
Shares:13.0K
Value:$56.8K
% of Portfolio:0.0% ($56.8K/$2.4B)
Aurora Innovation, Inc.
Shares:40.0K
Value:$56.4K
% of Portfolio:0.0% ($56.4K/$2.4B)
TERAWULF INC.
Shares:10.7K
Value:$29.3K
% of Portfolio:0.0% ($29.3K/$2.4B)
Alector, Inc.
Shares:10.0K
Value:$12.3K
% of Portfolio:0.0% ($12.3K/$2.4B)
Gossamer Bio, Inc.
Shares:10.0K
Value:$11.0K
% of Portfolio:0.0% ($11.0K/$2.4B)
92561V117
Shares:282.8K
Value:$10.2K
% of Portfolio:0.0% ($10.2K/$2.4B)
Spero Therapeutics, Inc.
Shares:10.0K
Value:$7.2K
% of Portfolio:0.0% ($7.2K/$2.4B)